Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Clinical trial NCT06344065 · RECRUITING

Trial details

NCT number: NCT06344065
Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-12-21
Primary completion: 2025-05-25
Enrollment: 1584

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.